Mirador Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $756K | Hold |
5,882
| – | – | 0.09% | 122 |
|
|
2026
Q1 | $708K | Sell |
5,882
-343
| -6% | -$39.6K | 0.1% | 111 |
|
|
2025
Q4 | $655K | Sell |
6,225
-273
| -4% | -$25.6K | 0.09% | 126 |
|
|
2025
Q3 | $545K | Buy |
6,498
+67
| +1% | +$5.52K | 0.08% | 139 |
|
|
2025
Q2 | $509K | Hold |
6,431
| – | – | 0.08% | 138 |
|
|
2025
Q1 | $577K | Buy |
6,431
+277
| +5% | +$25.9K | 0.1% | 123 |
|
|
2024
Q4 | $612K | Buy |
6,154
+243
| +4% | +$25.1K | 0.11% | 117 |
|
|
2024
Q3 | $671K | Buy |
5,911
+8
| +0.1% | +$950 | 0.12% | 112 |
|
|
2024
Q2 | $731K | Sell |
5,903
-634
| -10% | -$81.7K | 0.14% | 98 |
|
|
2024
Q1 | $863K | Buy |
6,537
+475
| +8% | +$58.5K | 0.16% | 97 |
|
|
2023
Q4 | $661K | Sell |
6,062
-191
| -3% | -$19.8K | 0.14% | 100 |
|
|
2023
Q3 | $644K | Sell |
6,253
-284
| -4% | -$30.6K | 0.15% | 103 |
|
|
2023
Q2 | $754K | Sell |
6,537
-102
| -2% | -$11.6K | 0.18% | 95 |
|
|
2023
Q1 | $706K | Sell |
6,639
-60
| -0.9% | -$6.48K | 0.17% | 89 |
|
|
2022
Q4 | $743K | Buy |
6,699
+1
| +0% | +$102 | 0.18% | 87 |
|
|
2022
Q3 | $577K | Sell |
6,698
-504
| -7% | -$45K | 0.14% | 99 |
|
|
2022
Q2 | $657K | Buy |
7,202
+1
| +0% | +$89 | 0.16% | 98 |
|
|
2022
Q1 | $591K | Sell |
7,201
-100
| -1% | -$7.88K | 0.12% | 127 |
|
|
2021
Q4 | $560K | Hold |
7,301
| – | – | 0.12% | 130 |
|
|
2021
Q3 | $548K | Buy |
7,301
+85
| +1% | +$6.46K | 0.12% | 126 |
|
|
2021
Q2 | $561K | Sell |
7,216
-529
| -7% | -$39.3K | 0.13% | 125 |
|
|
2021
Q1 | $570K | Buy |
7,745
+534
| +7% | +$39.4K | 0.15% | 112 |
|
|
2020
Q4 | $563K | Sell |
7,211
-16,050
| -69% | -$1.23M | 0.15% | 111 |
|
|
2020
Q3 | $1.84M | Sell |
23,261
-7,526
| -24% | -$589K | 0.57% | 52 |
|
|
2020
Q2 | $2.27M | Buy |
30,787
+469
| +2% | +$35.3K | 0.85% | 38 |
|
|
2020
Q1 | $2.23M | Buy |
30,318
+2,549
| +9% | +$200K | 0.93% | 35 |
|
|
2019
Q4 | $2.41M | Sell |
27,769
-322
| -1% | -$26.4K | 0.97% | 31 |
|
|
2019
Q3 | $2.26M | Buy |
28,091
+44
| +0.2% | +$3.53K | 1.01% | 31 |
|
|
2019
Q2 | $2.24M | Buy |
28,047
+20,232
| +259% | +$1.55M | 1.11% | 30 |
|
|
2019
Q1 | $620K | Buy |
7,815
+2,530
| +48% | +$189K | 0.34% | 72 |
|
|
2018
Q4 | $385K | Sell |
5,285
-439
| -8% | -$31K | 0.24% | 82 |
|
|
2018
Q3 | $387K | Sell |
5,724
-3
| -0.1% | -$191 | 0.19% | 102 |
|
|
2018
Q2 | $332K | Buy |
5,727
+494
| +9% | +$27.9K | 0.18% | 104 |
|
|
2018
Q1 | $294K | Sell |
5,233
-48
| -0.9% | -$2.59K | 0.21% | 93 |
|
|
2017
Q4 | $284K | Sell |
5,281
-24,241
| -82% | -$1.34M | 0.16% | 110 |
|
|
2017
Q3 | $1.82M | Buy |
29,522
+339
| +1% | +$20.6K | 1.07% | 33 |
|
|
2017
Q2 | $1.76M | Buy |
29,183
+514
| +2% | +$31.3K | 1.08% | 26 |
|
|
2017
Q1 | $1.74M | Sell |
28,669
-195
| -0.7% | -$11.8K | 1.27% | 24 |
|
|
2016
Q4 | $1.62M | Sell |
28,864
-1,694
| -6% | -$99.1K | 1.3% | 25 |
|
|
2016
Q3 | $1.82M | Sell |
30,558
-300
| -1% | -$17.5K | 1.6% | 18 |
|
|
2016
Q2 | $1.7M | Sell |
30,858
-1,745
| -5% | -$92.9K | 1.7% | 19 |
|
|
2016
Q1 | $1.65M | Buy |
+32,603
| New | +$1.6M | 1.82% | 15 |
|
Other funds holding MRK
ECSS
Mirador Capital Partners's MRK Position: Q2 2026 in Review
Mirador Capital Partners held its Merck (MRK) position steady in Q2 2026 at 5,882 shares worth $756K. The position accounts for 0.09% of the portfolio, ranked #122.
Mirador Capital Partners first reported a position in MRK in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.41M in Q4 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Mirador Capital Partners held 5,882 shares of Merck worth $756K as of Q2 2026.
- Mirador Capital Partners left its Merck share count unchanged in Q2 2026.
- Merck made up 0.09% of Mirador Capital Partners's portfolio in Q2 2026, its #122 holding.
- Mirador Capital Partners first reported a position in Merck in Q1 2016 and has held it in 42 quarters since.
- Mirador Capital Partners's Merck position peaked at $2.41M in Q4 2019.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.